GSKs Nuvalent deal tackles HIV cliff to win cautious backing from analysts
GSK PLCs (LSE:GSK, NYSE:GSK) $10.6 billion (£8bn) acquisition of US biotech Nuvalent has achieved something unusual in large pharmaceutical M&A: analysts...…
22,185€
0,38%
Echtzeit-Aktienkurs GSK PLC
Bid:
Ask:
Nachrichten zur GSK PLC Aktie
GSKs Nuvalent deal tackles HIV cliff to win cautious backing from analysts
GSK PLCs (LSE:GSK, NYSE:GSK) $10.6 billion (£8bn) acquisition of US biotech Nuvalent has achieved something unusual in large pharmaceutical M&A: analysts...…
ANALYSE-FLASH: Barclays belässt GSK auf 'Underweight' - Ziel 1800 Pence
LONDON (dpa-AFX Broker) - Die britische Investmentbank Barclays hat die Einstufung für GSK mit einem…
GSK falls as £8bn takeover of Nuvalent is largest deal in a decade
GSK PLC (LSE:GSK, NYSE:GSK) shares fell 3% after it agreed to acquire US biotechnology company Nuvalent (NASDAQ:NUVL) for $10.6 billion (£8.0…
GSK agrees £8bn Nuvalent takeover to bolster oncology pipeline
GSK PLC (LSE:GSK, NYSE:GSK) has agreed to acquire US biotechnology company Nuvalent for $10.6 billion (£8.0 billion), adding "immediate" new sales…
GSK falls after agreeing £8bn Nuvalent takeover to bolster oncology pipeline
GSK PLC (LSE:GSK, NYSE:GSK) shares fell 3% after it agreed to acquire US biotechnology company Nuvalent (NASDAQ:NUVL) for $10.6 billion (£8.0 billion),...…
US bank sees GSK oncology pipeline as major value driver after New York conference
Jefferies has flagged four near-term catalysts in GSK PLCs (LSE:GSK, NYSE:GSK) oncology pipeline following a fireside chat with the pharmaceutical...…
GSK hepatitis B drug a long-term opportunity but US bank holds back from upgrading
Citi is holding back from recommending GSK PLC (LSE:GSK, NYSE:GSK) shares despite a significant clinical breakthrough in hepatitis B treatment, arguing…
GSK Aktie: Starke Zahlen, schwache Pipeline
Wien (www.aktiencheck.de) - GSK-Aktienanalyse von der Raiffeisen Bank International AG:Julian Lindinger, Analyst der Raiffeisen Bank International AG (RBI), nimmt die…
ANALYSE-FLASH: DZ Bank senkt Ziel für GSK auf 2100 Pence - 'Halten'
FRANKFURT (dpa-AFX) - Die DZ Bank hat das Kursziel für GSK nach Quartalszahlen von 2200…
GSK Quartalszahlen Q1: Umsatz und Gewinn über Erwartungen
Wien (www.aktiencheck.de) - GSK-Aktienanalyse von der Raiffeisen Bank International AG:Julian Lindinger, Analyst der Raiffeisen Bank International AG (RBI), nimmt die…
Pharmakonzern GSK startet überraschend stark ins Jahr - Aktie aber unter Druck
LONDON (dpa-AFX) - Der britische Pharmakonzern GSK hat im ersten Quartal von einer starken Nachfrage…
GSK reaffirms 2026 guidance after strong first-quarter performance
GSK PLC (LSE:GSK, NYSE:GSK), the FTSE 100 pharmaceuticals giant, has reiterated its full-year 2026 guidance after delivering a strong first…
GSK unit wins partial dismissal in dostarlimab licence dispute with AnaptysBio
GSK PLCs (LSE:GSK, NYSE:GSK) oncology subsidiary TESARO has secured a partial legal victory after a Delaware court dismissed a counterclaim brought…
GSK plc (GSK) Presents at Goldman Sachs 9th Annual Biopharma Innovation Summit Transcript
…
Broker reiterates GSK buy as court ruling lifts vaccine cloud
Shore Capital has reiterated its buy recommendation on GSK PLC (LSE:GSK, NYSE:GSK) with a fair value of 2,500p, arguing the pharmaceutical…
Broker reiterates GSK buy as court ruling lifts vaccine cloud
Shore Capital has reiterated its buy recommendation on GSK PLC (LSE:GSK, NYSE:GSK) with a fair value of 2,500p, arguing the pharmaceutical…
GSK sells rights to rare liver disease drug for up to $690m
The British pharma giant will hand off its experimental itch treatment to Italian company Alfasigma as it focuses on broader…
GSK pays $950m for a pulmonary hypertension drug designed to avoid the bleeding risk that limits rival treatments
GSK PLC (LSE:GSK, NYSE:GSK) has agreed to acquire Canadian biotech 35Pharma for $950 million in cash, securing a clinical-stage drug for…
Citi lifts GSK target price but keeps neutral stance after rally
Citi has raised its price target for GSK PLC (LSE:GSK, NYSE:GSK) to £22.50 while maintaining a neutral rating, citing a sharp rally…
ROUNDUP: Pharmakonzern GSK schlägt sich besser als erwartet - Ziele bestätigt
LONDON (dpa-AFX) - Der Pharmakonzern GSK hat dank eines unerwartet starken Schlussspurts im abgelaufenen Jahr…
Pharmakonzern GSK schlägt sich besser als erwartet - Ziele bestätigt
LONDON (dpa-AFX) - Der Pharmakonzern GSK hat dank eines unerwartet starken Schlussspurts im abgelaufenen Jahr…
GSK Aktie: Langsameres Wachstum in 2026
Wien (www.aktiencheck.de) - GSK-Aktienanalyse von der Raiffeisen Bank International AG:Julian Lindinger, Analyst der Raiffeisen Bank International AG (RBI), nimmt die…
GSK delivers solid 2025 results, reaffirms growth outlook for 2026
Specialty Medicines drive strong sales as company maintains guidance and raises dividend GSK PLC (LSE:GSK, NYSE:GSK) reported a 7% rise in sales…
GSK snaps up food allergy drug specialist RAPT for $2.2bn
GSK PLC (LSE:GSK, NYSE:GSK) has struck a $2.2 billion deal to buy US biotech firm RAPT Therapeutics, adding a potential new…
GSK reports breakthrough trial results for hepatitis B drug
GSK PLC (LSE:GSK, NYSE:GSK) said on Wednesday that a potential new treatment for chronic hepatitis B had delivered positive late-stage…
GSKs asthma treatment gets greenlight in Japan
GSK PLC (LSE:GSK, NYSE:GSK) said Japan has approved Exdensur (depemokimab) to treat severe or refractory bronchial asthma and chronic rhinosinusitis…
GSK is next to agree drug pricing deal with US government
GSK PLC (LSE:GSK, NYSE:GSK) has become the latest big pharma company to fall into line with the US governments "most favoured…
FTSE 100 Live: London stocks to take a dip, GSK agrees UK pricing deal, Rank hit by fraud
8am: GSK agrees drug pricing deal to avoid tariffs GSK PLC (LSE:GSK, NYSE:GSK) has become the latest big pharma company to…
GSK drug for aggressive lung cancer wins US orphan status
GSK PLC (LSE:GSK, NYSE:GSK) has picked up another regulatory boost for its experimental cancer medicine risvutatug rezetecan, after the US Food…
GSK unit sues AnaptysBio in row over Jemperli rights
GSK PLC (LSE:GSK, NYSE:GSK) has stepped up a dispute over rights to its fast-growing cancer drug Jemperli by having its US…
FTSE 100 Live: Stocks to plunge after wild ride on Wall Street, as bitcoin tumbles
7.54am: GSK steps up US dispute GSK PLC (LSE:GSK, NYSE:GSK) has stepped up a dispute over rights to its fast-growing cancer…
GSK Aktie: Zeit für eine Verschnaufpause
Wien (www.aktiencheck.de) - GSK-Aktienanalyse von der Raiffeisen Bank International AG:Julian Lindinger, Analyst der Raiffeisen Bank International AG (RBI), stuft die…
GSK’s shares stuck in the middle lane
GSK PLCs (LSE:GSK, NYSE:GSK) latest quarter looked strong enough on pape, but the share price barely moved. The drugmaker has spent much…
GSK’s shares stuck in the middle lane
GSK PLCs (LSE:GSK, NYSE:GSK) latest quarter looked strong enough on pape, but the share price barely moved. The drugmaker has spent much…
GSK delivers one of its cleaner beats, says leading bank
After Wednesdays results, GSK PLC (LSE:GSK, NYSE:GSK) looks to have delivered one of its cleaner beats in recent quarters. Third-quarter numbers…
GSK raises its sights after strong quarter and upgraded outlook
GSK PLCs (LSE:GSK, NYSE:GSK) third-quarter results offered the kind of clean beat investors like to see. Sales came in 4% ahead…
AKTIE IM FOKUS: Optimistischere Jahresziele katapultieren GSK nach oben
LONDON (dpa-AFX Broker) - Eine Anhebung der Jahresziele hat am Mittwoch die Aktien von GSK …
Pharmakonzern GSK hebt nach unerwartet starkem Quartal nochmals Jahresziele an
LONDON (dpa-AFX) - Der britische Arzneimittelhersteller GSK hat ein weiteres Quartal unerwartet stark abgeschlossen. Konzernchefin…
GSK lifts profit outlook after strong quarter and upbeat broker reaction
GSK PLC (LSE:GSK, NYSE:GSK) shares rose 4% to 1,707p after the pharmaceutical group raised its full-year guidance and delivered quarterly results…
GSK Aktie: Starke Q3-Zahlen - Ausblick erneut angehoben
Wien (www.aktiencheck.de) - GSK-Aktienanalyse von der Raiffeisen Bank International AG:Julian Lindinger, Analyst der Raiffeisen Bank International AG (RBI), nimmt die…
GSK cancer drug wins EU orphan status for small-cell lung cancer
GSK PLC (LSE:GSK, NYSE:GSK) has secured Orphan Drug Designation in the European Union for GSK5764227, also known as GSK’227, a B7-H3-targeted…
ANALYSE-FLASH: Jefferies hebt GSK auf 'Buy' - Ziel hoch auf 2000 Pence
NEW YORK (dpa-AFX) - Das Analysehaus Jefferies hat das Kursziel für die Aktien von GSK …
ANALYSE-FLASH: JPMorgan belässt GSK auf 'Underweight' - Ziel 1400 Pence
NEW YORK (dpa-AFX Broker) - Die US-Bank JPMorgan hat die Einstufung für GSK mit einem…
GSK erhält Zulassung für Blutkrebsmedikament in den USA
LONDON (dpa-AFX) - Der britische Pharmakonzern GSK kann sein Blutkrebsmedikament Blenrep als Kombinationstherapie wieder in…
GSK und US-Partner Alector stellen Tests an Demenzmittel nach Studienflop ein
LONDON (dpa-AFX) - Der Pharmakonzern GSK hat einen Flop bei seinen Forschungsarbeiten an einem Demenzmittel…
Pharmakonzern GSK bekommt neuen Unternehmenschef
LONDON (dpa-AFX) - Der britische Arzneimittelhersteller GSK wird ab dem kommenden Jahr einen neuen Unternehmenschef…
GSK chief exec Emma Walmsley to leave in January
GSK PLC (LSE:GSK, NYSE:GSK) chief executive Dame Emma Walmsley will step down from 1 January next year after almost nine years…
GSK chief exec Emma Walmsley to step down at end of December
GSK PLC (LSE:GSK, NYSE:GSK) chief executive Dame Emma Walmsley will step down at the end of December this year after almost…
GSK chief exec Emma Walmsley to step down at end of December
GSK PLC (LSE:GSK, NYSE:GSK) chief executive Dame Emma Walmsley will step down at the end of December this year after almost…